Oculis Holding Ag Stock Today

OCSAW Stock   4.25  0.04  0.93%   

Performance

10 of 100

 
Weak
 
Strong
OK

Odds Of Distress

Over 72

 
High
 
Low
High
Oculis Holding is selling for under 4.25 as of the 3rd of December 2024; that is 0.93 percent down since the beginning of the trading day. The stock's lowest day price was 4.24. Oculis Holding has a very high chance of experiencing financial distress in the next few years of operation. However, it had a very ok returns during the last 90 days. Equity ratings for Oculis Holding AG are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of November 2024 and ending today, the 3rd of December 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
3rd of March 2023
Category
Healthcare
Classification
Health Care
Oculis Holding is entity of United States. It is traded as Stock on NASDAQ exchange. More on Oculis Holding AG

Moving against Oculis Stock

  0.72ME 23Andme HoldingPairCorr
  0.63DRMA Dermata TherapeuticsPairCorr
  0.61DOMH Dominari HoldingsPairCorr
  0.54A Agilent TechnologiesPairCorr
  0.51VALN Valneva SE ADRPairCorr
  0.39VCNX VaccinexPairCorr

Oculis Stock Highlights

Business ConcentrationBiotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors)
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Net Debt80.3 M118.1 M
Way Down
Slightly volatile
Total Current Liabilities10.9 M19.1 M
Way Down
Slightly volatile
Non Current Liabilities Total1.5 M1.5 M
Notably Down
Very volatile
Total Assets62.1 M114.4 M
Way Down
Slightly volatile
Total Current Assets106.1 M101 M
Sufficiently Up
Slightly volatile
Oculis Holding can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Oculis Holding's financial leverage. It provides some insight into what part of Oculis Holding's total assets is financed by creditors.
Liquidity
Oculis Holding AG has accumulated 20.62 M in total debt. Note, when we think about Oculis Holding's use of debt, we should always consider it together with its cash and equity.

Issuance Of Capital Stock

142.4 Million
Oculis Holding AG (OCSAW) is traded on NASDAQ Exchange in USA. It is located in null and employs 32 people. Oculis Holding is listed under Biotechnology category by Fama And French industry classification. The company classifies itself under Biotechnology sector and is part of Health Care industry. Oculis Holding generates negative cash flow from operations
Check Oculis Holding Probability Of Bankruptcy

Oculis Holding Historical Income Statement

At this time, Oculis Holding's Net Interest Income is fairly stable compared to the past year. Interest Income is likely to climb to about 1.5 M in 2024, whereas Interest Expense is likely to drop slightly above 1.2 M in 2024. View More Fundamentals

Oculis Stock Against Markets

Additional Tools for Oculis Stock Analysis

When running Oculis Holding's price analysis, check to measure Oculis Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oculis Holding is operating at the current time. Most of Oculis Holding's value examination focuses on studying past and present price action to predict the probability of Oculis Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oculis Holding's price. Additionally, you may evaluate how the addition of Oculis Holding to your portfolios can decrease your overall portfolio volatility.